CMR in Transcatheter Valve Interventions: State of the Art and Future Directions
- 20 Downloads
Purpose of Review
Transcatheter valve interventions require careful planning and rely heavily on multimodality imaging. In contrast to echocardiography and computed tomography cardiovascular magnetic resonance (CMR) remains underused in clinical practice.
CMR techniques such as multiplanar cine imaging unlimited by echo windows or ionizing radiation exposure, quantification of flow, and advanced tissue characterization have the potential to add valuable complimentary information to the evaluation of patients with valvular heart disease.
In this paper, we review the evidence for CMR to guide transcatheter valve interventions with a focus on practical applications for the interventionist.
KeywordsCardiovascular magnetic resonance Valvular heart disease Transcatheter interventions
Cardiovascular magnetic resonance
Transcatheter aortic valve replacement
All authors contributed to the study design, data analysis, and/or manuscript preparation. All authors have read and approved the final manuscript.
Compliance with Ethical Standards
Conflict of Interest
Toby Rogers is a Consultant and Physician Proctor to Medtronic and a Physician Proctor to Edwards Lifesciences.
Kanishka Ratnayaka declares that he has no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 6.• Zoghbi WA, Adams D, Bonow RO, Enriquez-Sarano M, Foster E, Grayburn PA, et al. Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr. 2017;30(4):303–71 These recommendations summarize the complimentary role of echocardiography and CMR in the evaluation of patients with valvular regurgitation. Google Scholar
- 12.Mayr A, Klug G, Reinstadler SJ, Feistritzer HJ, Reindl M, Kremser C, et al. Is MRI equivalent to CT in the guidance of TAVR? A pilot study. Eur Radiol. 2018. https://doi.org/10.1007/s00330-018-5386-2. [Epub ahead of print].
- 14.Kammerlander AA, Wiesinger M, Duca F, Aschauer S, Binder C, Zotter Tufaro C, et al. Diagnostic and prognostic utility of cardiac magnetic resonance imaging in aortic regurgitation. JACC Cardiovasc Imaging. 2018. https://doi.org/10.1016/j.jcmg.2018.08.036. [Epub ahead of print].
- 15.Rodriguez-Palomares JF, Dux-Santoy L, Guala A, Kale R, Maldonado G, Teixido-Tura G, et al. Aortic flow patterns and wall shear stress maps by 4D-flow cardiovascular magnetic resonance in the assessment of aortic dilatation in bicuspid aortic valve disease. J Cardiovasc Magn Reson. 2018;20(1):28.CrossRefGoogle Scholar
- 16.• Musa TA, Treibel TA, Vassiliou VS, Captur G, Singh A, Chin C, et al. Myocardial scar and mortality in severe aortic stenosis. Circulation, This study demonstrated that late gadolinium enhancement was independently associated with mortality in patients with severe aortic stenosis. 2018;138(18):1935–47.Google Scholar
- 18.Treibel TA, Fontana M, Gilbertson JA, Castelletti S, White SK, Scully PR, et al. Occult transthyretin cardiac amyloid in severe calcific aortic stenosis: prevalence and prognosis in patients undergoing surgical aortic valve replacement. Circ Cardiovasc Imaging. 2016;9(8).Google Scholar
- 24.Penicka M, Vecera J, Mirica DC, Kotrc M, Kockova R, Van Camp G. Prognostic implications of magnetic resonance-derived quantification in asymptomatic patients with organic mitral regurgitation: comparison with Doppler echocardiography-derived integrative approach. Circulation. 2018;137(13):1349–60.CrossRefGoogle Scholar
- 25.•• Stone GW, Lindenfeld J, Abraham WT, Kar S, Lim DS, Mishell JM, et al. Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med, Landmark paper demonstrating for the first time a mortality benefit from transcatheter mitral valve repair. 2018.Google Scholar
- 27.Stout KK, Daniels CJ, Aboulhosn JA, Bozkurt B, Broberg CS, Colman JM, et al. 2018 AHA/ACC guideline for the management of adults with congenital heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2018. https://doi.org/10.1016/j.jacc.2018.08.1028. [Epub ahead of print].
- 28.Schievano S, Coats L, Migliavacca F, Norman W, Frigiola A, Deanfield J, et al. Variations in right ventricular outflow tract morphology following repair of congenital heart disease: implications for percutaneous pulmonary valve implantation. J Cardiovasc Magn Reson. 2007;9(4):687–95.CrossRefGoogle Scholar
- 33.Martin MH, Meadows J, McElhinney DB, Goldstein BH, Bergersen L, Qureshi AM, et al. Safety and feasibility of melody transcatheter pulmonary valve replacement in the native right ventricular outflow tract: A Multicenter Pediatric Heart Network Scholar Study. JACC Cardiovasc Interv. 2018;11(16):1642–50.CrossRefGoogle Scholar
- 36.Kenny D, Hijazi ZM, Kar S, Rhodes J, Mullen M, Makkar R, et al. Percutaneous implantation of the Edwards SAPIEN transcatheter heart valve for conduit failure in the pulmonary position: early phase 1 results from an international multicenter clinical trial. J Am Coll Cardiol. 2011;58(21):2248–56.CrossRefGoogle Scholar
- 40.Basar B, Rogers T, Ratnayaka K, Campbell-Washburn AE, Mazal JR, Schenke WH, et al. Segmented nitinol guidewires with stiffness-matched connectors for cardiovascular magnetic resonance catheterization: preserved mechanical performance and freedom from heating. J Cardiovasc Magn Reson. 2015;17(1):105.CrossRefGoogle Scholar